Compare $IMUC vs $PHIO | Chartloom

Compare

$IMUC vs $PHIO

Eom Pharmaceutical Holdings Inc · Phio Pharmaceuticals Corp

IMUC

Eom Pharmaceutical Holdings Inc

PHIO

Phio Pharmaceuticals Corp

Compare $IMUC vs $PHIO

Comparing Eom Pharmaceutical Holdings Inc and Phio Pharmaceuticals Corp

IMUCEom Pharmaceutical Holdings Inc

PHIOPhio Pharmaceuticals Corp

IMUCEom Pharmaceutical Holdings Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.3%

52W performance

-31.7%

FCF yield

-18.9%

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUC

PHIO

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

IMUC$12M

PHIO$11M

Enterprise Value

IMUC$14M

PHIO$-2M

Price

IMUC$0.10

PHIO$0.98

P/E Ratio

IMUCN/A

PHION/A

P/S Ratio

IMUC0.00x

PHIO81.74x

EV/Sales

IMUC0.00x

PHIO-11.08x

EV/EBITDA

IMUC0.00x

PHIO0.00x

P/B Ratio

IMUC3.51x

PHIO0.91x

P/FCF Ratio

IMUCN/A

PHION/A

EV/FCF

IMUC-6.11x

PHIO0.13x

PEG Ratio

IMUCN/A

PHION/A

Forward P/E (NTM)

IMUCN/A

PHION/A

Forward P/S (NTM)

IMUCN/A

PHION/A

Revenue (TTM)

IMUC$0

PHIO$0

Revenue Growth (YoY)

IMUCN/A

PHION/A

Forward Rev Growth

IMUC0.0%

PHIO0.0%

Gross Margin (TTM)

IMUC0.0%

PHIO0.0%

Operating Margin (TTM)

IMUC0.0%

PHIO0.0%

EBITDA Margin (TTM)

IMUC0.0%

PHIO0.0%

Net Margin (TTM)

IMUC0.0%

PHIO0.0%

FCF Margin (TTM)

IMUCN/A

PHION/A

Net Income (TTM)

IMUC$-6M

PHIO$-13M

FCF (TTM)

IMUC$-2M

PHIO$-12M

EPS (TTM)

IMUC-$0.05

PHIO-$1.11

ROE (TTM)

IMUC-4502.0%

PHIO-8741.0%

ROA (TTM)

IMUC-45737.0%

PHIO-7976.0%

ROIC (TTM)

IMUC-4502.0%

PHIO-8741.0%

Cash

IMUC$933K

PHIO$13M

Debt

IMUC$3M

PHIO$0

Net Cash/Debt

IMUC$-2M

PHIO$13M

Current Ratio (TTM)

IMUC1.51x

PHIO8.39x

Quick Ratio (TTM)

IMUC1.28x

PHIO7.62x

Debt/Equity (TTM)

IMUC0.00x

PHIO0.00x

Debt/Assets (TTM)

IMUC0.0%

PHIO0.0%

Interest Coverage (TTM)

IMUCN/A

PHION/A

Net Debt/EBITDA (TTM)

IMUC0.00x

PHIO0.00x

Beta

IMUC0.80

PHIO0.90

52W Performance

IMUC-31.7%

PHIO-59.6%

YTD Performance

IMUC-51.3%

PHIO-10.2%

% from 52W High

IMUC-72.1%

PHIO-76.6%

% from 52W Low

IMUC375.0%

PHIO20.8%

Asset Turnover (TTM)

IMUC0.00x

PHIO0.02x

FCF Yield (TTM)

IMUC-18.9%

PHIO-107.3%

Earnings Yield (TTM)

IMUC-49.4%

PHIO-113.5%

Dividend Yield (TTM)

IMUCN/A

PHION/A

Rule of 40

IMUC0.0

PHIO0.0

EV/GP/RG

IMUCN/A

PHION/A

Ticker research

View IMUC research View PHIO research

Metric	IMUC Eom Pharmaceutical Holdings Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$12M	$11M
Enterprise Value	$14M	$-2M
Price	$0.10	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-13M
FCF (TTM)	$-2M	$-12M
EPS (TTM)	-$0.05	-$1.11
ROE (TTM)	-4502.0%	-8741.0%
ROA (TTM)	-45737.0%	-7976.0%
ROIC (TTM)	-4502.0%	-8741.0%
Financial Health
Cash	$933K	$13M
Debt	$3M	$0
Net Cash/Debt	$-2M	$13M
Current Ratio (TTM)	1.51x	8.39x
Quick Ratio (TTM)	1.28x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	0.90
52W Performance	-31.7%	-59.6%
YTD Performance	-51.3%	-10.2%
% from 52W High	-72.1%	-76.6%
% from 52W Low	375.0%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-18.9%	-107.3%
Earnings Yield (TTM)	-49.4%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View PHIO research

Valuation

P/S Ratio

IMUC

0.00x

PHIO

81.74x

EV/FCF

IMUC

-6.11x

PHIO

0.13x

Growth & revenue

Forward Revenue Growth

IMUC

0.0%

PHIO

0.0%

Profitability & performance

Gross Margin

IMUC

0.0%

PHIO

0.0%

ROE

IMUC

-4502.0%

PHIO

-8741.0%

FCF Yield %

IMUC

-18.9%

PHIO

-107.3%

52-Week Performance

IMUC

-31.7%

PHIO

-59.6%

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

IMUC$12M

PHIO$11M

Enterprise Value

IMUC$14M

PHIO$-2M

Price

IMUC$0.10

PHIO$0.98

P/E Ratio

IMUCN/A

PHION/A

P/S Ratio

IMUC0.00x

PHIO81.74x

EV/Sales

IMUC0.00x

PHIO-11.08x

EV/EBITDA

IMUC0.00x

PHIO0.00x

P/B Ratio

IMUC3.51x

PHIO0.91x

P/FCF Ratio

IMUCN/A

PHION/A

EV/FCF

IMUC-6.11x

PHIO0.13x

PEG Ratio

IMUCN/A

PHION/A

Forward P/E (NTM)

IMUCN/A

PHION/A

Forward P/S (NTM)

IMUCN/A

PHION/A

Revenue (TTM)

IMUC$0

PHIO$0

Revenue Growth (YoY)

IMUCN/A

PHION/A

Forward Rev Growth

IMUC0.0%

PHIO0.0%

Gross Margin (TTM)

IMUC0.0%

PHIO0.0%

Operating Margin (TTM)

IMUC0.0%

PHIO0.0%

EBITDA Margin (TTM)

IMUC0.0%

PHIO0.0%

Net Margin (TTM)

IMUC0.0%

PHIO0.0%

FCF Margin (TTM)

IMUCN/A

PHION/A

Net Income (TTM)

IMUC$-6M

PHIO$-13M

FCF (TTM)

IMUC$-2M

PHIO$-12M

EPS (TTM)

IMUC-$0.05

PHIO-$1.11

ROE (TTM)

IMUC-4502.0%

PHIO-8741.0%

ROA (TTM)

IMUC-45737.0%

PHIO-7976.0%

ROIC (TTM)

IMUC-4502.0%

PHIO-8741.0%

Cash

IMUC$933K

PHIO$13M

Debt

IMUC$3M

PHIO$0

Net Cash/Debt

IMUC$-2M

PHIO$13M

Current Ratio (TTM)

IMUC1.51x

PHIO8.39x

Quick Ratio (TTM)

IMUC1.28x

PHIO7.62x

Debt/Equity (TTM)

IMUC0.00x

PHIO0.00x

Debt/Assets (TTM)

IMUC0.0%

PHIO0.0%

Interest Coverage (TTM)

IMUCN/A

PHION/A

Net Debt/EBITDA (TTM)

IMUC0.00x

PHIO0.00x

Beta

IMUC0.80

PHIO0.90

52W Performance

IMUC-31.7%

PHIO-59.6%

YTD Performance

IMUC-51.3%

PHIO-10.2%

% from 52W High

IMUC-72.1%

PHIO-76.6%

% from 52W Low

IMUC375.0%

PHIO20.8%

Asset Turnover (TTM)

IMUC0.00x

PHIO0.02x

FCF Yield (TTM)

IMUC-18.9%

PHIO-107.3%

Earnings Yield (TTM)

IMUC-49.4%

PHIO-113.5%

Dividend Yield (TTM)

IMUCN/A

PHION/A

Rule of 40

IMUC0.0

PHIO0.0

EV/GP/RG

IMUCN/A

PHION/A

Ticker research

View IMUC research View PHIO research

Metric	IMUC Eom Pharmaceutical Holdings Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$12M	$11M
Enterprise Value	$14M	$-2M
Price	$0.10	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-13M
FCF (TTM)	$-2M	$-12M
EPS (TTM)	-$0.05	-$1.11
ROE (TTM)	-4502.0%	-8741.0%
ROA (TTM)	-45737.0%	-7976.0%
ROIC (TTM)	-4502.0%	-8741.0%
Financial Health
Cash	$933K	$13M
Debt	$3M	$0
Net Cash/Debt	$-2M	$13M
Current Ratio (TTM)	1.51x	8.39x
Quick Ratio (TTM)	1.28x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	0.90
52W Performance	-31.7%	-59.6%
YTD Performance	-51.3%	-10.2%
% from 52W High	-72.1%	-76.6%
% from 52W Low	375.0%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-18.9%	-107.3%
Earnings Yield (TTM)	-49.4%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View PHIO research